SCHEMBL31233173

SCHEMBL31233173

COc1ccc(/C=C/C(=O)c2ccc(O)cc2)cc1COc1ccc(Cl)cc1

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.81
▸ KMT2A Q03164 5/20 0.81
▸ LMNA P02545 5/20 0.81
▸ ALDH1A1 P00352 3/20 0.81
▸ KDM4E B2RXH2 3/20 0.81
▸ ABCG2 Q9UNQ0 3/20 0.65
▸ MAPT P10636 5/20 0.63
▸ THRB P10828 1/20 0.63
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ CXCL12 P48061 2/20 0.61
▸ CXCR4 P61073 1/20 0.61
▸ CTSL P07711 1/20 0.58
▸ MAOB P27338 4/20 0.58
▸ MAOA P21397 1/20 0.58
▸ P4HB P07237 1/20 0.56
▸ CALM1 P0DP23 1/20 0.56
▸ RAB9A P51151 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25207663 1.00 MEN1 (0.81) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL31233297 1.00 MEN1 (0.81) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25234254 1.00 MEN1 (0.81) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25198797 0.92 MEN1 (0.86) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25195235 0.90 MEN1 (0.82) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL30382681 0.90 MEN1 (0.78) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25208719 0.90 MEN1 (0.78) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL31233303 0.90 MEN1 (0.71) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25205516 0.90 MEN1 (0.71) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL25219934 0.90 MEN1 (0.78) MEN1KMT2ALMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 — — WO disclosed
Send feedback